SV40 tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFβ

International Journal of Cancer

Volumn 77, Issue 3, 1998, Pages 429-439

  Khoo, Nelson K S ^a   Bechberger, John F ^a   Shepherd, Trevor ^a   Bond, Shari L ^a   Mccrae, Keith R ^b   Scot Hamilton, G ^a   Lala, Peeyush K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; FIRST TRIMESTER PREGNANCY; GROWTH REGULATION; HUMAN; HUMAN CELL; PRECANCER; PRIORITY JOURNAL; SIMIAN VIRUS 40; TROPHOBLAST;

ANIMALS; ANTIGENS, VIRAL, TUMOR; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHORIOCARCINOMA; CLONE CELLS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PHENOTYPE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRECANCEROUS CONDITIONS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SIMIAN VIRUS 40; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 0031807395     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980729)77:3<429::AID-IJC20>3.0.CO;2-1     Document Type: Article

References (50)

1. ABOAGYE-MATHIESEN, G., ZDRAVKOVIC, M., LALA, P.K., GRAHAM, C.G. and EBBESEN, P., Overexpression of the tumor suppressor/oncoprotein p53 in SV40 transformed human placental trophoblast and choriocarcinoma cell lines. Early Pregnancy Biol. Med., 2, 102-112 (1996).
2. ALBINI, A., MELCHIRI, A., SANTI, L., LIOTTA, L.A., BROWN, P.D. and STETLER-STEVENSON, W.G., Tumor cell invasion inhibited by TIMP-2. J. nat. Cancer Inst., 83, 775-779 (1991).
3. BRADFORD, M..M., A rapid and sensitive method for the quantitation of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
4. CHAMBERS, A.F., COLELLA, R., DENHARDT, D.T. and WILSON, S.M., Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic ras-transformed NIH 3T3 cells. Mol. Carcinogen., 5, 238-245 (1992).
5. CIARDIELLO, F., DONO, R., KIM, N., PERSICO, M.G. and SALOMON, D.S., Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res., 51, 1051-1054 (1991).
6. DE WINTER, J.P., ROELEN, B.A.J., TEN DIJKE, P., VAN DER BURG, B. and VAN DEN EUNDEN-VAN RAAIJ, A.J.M., DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumor cells. Oncogene, 14, 1891-1899 (1997).
7. FEINBERG, R.F., KAO, L.-C., HAIMOWITZ, J.E., QUEENAN, J.T., JR, WUN, T.C., STRAUSS, J.F., III and KLIMAN, H.J., Plasminogen activator inhibitor types 1 and 2 in human trophoblasts: PAI-I is an immuhocytochemical marker for invading trophoblasts. Lab. Invest., 61, 20-26 (1989).
8. GARRIGUE-ANTAR, L., MUNOZ-ANTONIA, T., ANTONIA, S., GESMONDE, J., VELLUCI, V. and REISS, M., Missense mutations of the transforming growth factor β (TGF-β) type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55, 3982-3987 (1995).
9. GRAHAM, C.H., CONNELLY, I.H., MACDOUGALL, J.R., KERBEL, R.S., STETLER-STEVENSON, W.G. and LALA, P.K., Resistance of malignant trophoblast cells to both anti- proliferative and anti-invasive effects of transforming growth factor β. Exp. Cell Res., 214, 93-99 (1994).
10. GRAHAM, C.H., HAWLEY, T.S., HAWLEY, R.G., MACDOUGALL, J.R., KERBEL, R.S., KHOO, N.K.S. and LALA, P.K., Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res., 206, 204-211 (1993).
11. GRAHAM, C.H. and LALA. P.K., Mechanisms of placental invasion of the uterus and their control. Biochem. Cell Biol., 70, 867-874 (1992).
12. GRAHAM, C.H. and LALA, P.K., Mechanism of control of trophoblast invasion in situ. J. cell. Physiol., 148, 228-234 (1991).
13. GRAHAM, C.H., LYSIAK, J.J., MCCRAE, K.R. and LALA, P.K., Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod., 46, 561-572 (1992).
14. IRVING, J.A. and LALA, P.K., Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGFβ, IGF-II and IGFBP-1. Exp. Cell Res., 217, 419-427 (1995).
15. IRVING, J.A., LYSIAK, J.J., GRAHAM, G.G., HEARNS, S., HAN, V.K.M. and LALA, P.K., Characterization of trophoblast cells migrating from first trimester human chorionic villus expiants propagated in culture. Placenta, 16, 413-433 (1995).
16. KATAOKA, H., DECASTRO, R., ZUCKER, S. and BISWAS, C., Tumor cellderived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kD gelatinase. Cancer Res., 53, 3154-3158 (1993).
17. KHOKHA, R., WATERHOUSE, P., YAGEL, S., LALA, P.K., OVERALL, C.M., NORTON, G. and DENHARDT, D.T., Antisense RNA-induced reduction of murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science, 243, 947-950 (1989).
18. KHOKHA, R., ZIMMER, M.J., WILSON, S.M., GRAHAM, C.H., LALA, P.K. and WATERHOUSE, P., Suppression of invasion of inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16F10 melanoma cells. J. nat. Cancer Inst., 84, 1017-1022 (1992).
19. KHOO, N.K.S., CONNELLY, I.H., LYSIAK, J.J., BECHBERGER, J.F. and LALA, P.K., Regulation of nm23 gene expression in the normal and malignant trophoblast by growth factors. Trophoblast Res., 8, 303-314 (1994).
20. KHOO, N.K.S., ZHANG, Y., BECHBERGER, J.F., BOND, S.L, HUM, K. and LALA, P.K., SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. II. Changes in sap junctional intercellular communication. Int. J. Cancer, 77, 440-448 (1998).
21. KIM, S.K., FAN, Y., VALI, P., CLAYMAN, G., HITTELMAN, W.N., HONG, W.K., LOTAN, R. and MAO, L., DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res., 56, 2519-2521 (1996).
22. KIRBY, D.R.S., The development of mouse eggs beneath the kidney capsule. Nature (Lond.), 187, 707-708 (1960).
23. KUHAR, S.G. and LEHMAN, J.M., T antigen and p53 in pre- and post-crisis simian virus 40-transformed human cell lines. Oncogene, 6, 1499-1506 (1991).
24. LALA, P.K. and CONNELLY, I.H., Effects of type IV collagenase antisense oligonucleotides on invasiveness of normal and malignant trophoblast cells. Proc. Amer. Assoc. Cancer Res., 35, 614, (Abstract) (1994).
25. LALA, P.K. and GRAHAM, C.H., Mechanisms of trophoblast invasiveness and their invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev., 9, 369-379 (1990).
26. LALA, P.K. and HAMILTON, G.S., Growth factors, proteases and protease inhibitors in the maternal fetal dialogue. Placenta, 17, 545-555 (1996).
27. LALA, P.K. and LYSIAK, J.J., Autocrine-paracrine regulation of human placental growth and invasion by locally active growth factors. In: M. Kurpisz and N. Fernandez (eds.), Immunology of human reproduction, pp.235-249, Bios, Oxford, UK (1995).
28. LEHTOVIRTA, J. and VARTIO, T., Type IV collagenases in human amniotic fluids and amnion epithelial cells. Biochim. biophys. Acta., 1206, 83-89 (1994).
29. LIN, J.Y. and SIMMONS, D.T., The ability of large T antigen to complex with p53 is necessary for the increased lifespan and partial transformation of human cells by simian virus 40. J. Virol., 65, 6447-6453 (1991).
30. LU, C.K. and KERBEL, R.S., Interleukin 6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression [published erratum appears in J. Cell Biol. 1993 121 following p. 477]. J. Cell Biol., 120, 1281-1288 (1993).
31. LU, C., VICKERS, M.F. and KERBEL, R.S., Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. nat. Acad. Sci. (WASH.), 89, 9215-9219 (1992).
32. LUDLOW, J.W., Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. [Review]. FASEB J., 7, 866-871 (1993).
33. LUDLOW, J.W., DECAPRIO, J.A., HUANG, C-M., LEE, W-H., PAUCHA, E. and LIVINOSTON, D.M., SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell, 56, 57-65 (1989).
34. MYEROFF, L. and 16 OTHERS, A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55, 5545-5547 (1995).
35. NAGATAKE, M., TAKAGI, Y., OSADA, H., UCHIDA, K., MITSUDOMI, T., SAJI, S., SHIMOKATA, K., TAKAHASHI, T. and TAKAHASHI, T., Somatic 'in vivo' alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56, 2718-2720 (1996).
36. NAWROCKI, B., POLETTE, M., MARCHAND, V., MAQUOI, E., BEORCHIA, A., TOURNIERE, J.M., FOIDART, J-M. and BIREMBAUT, P., Membrane-type matrix metalloproteinase expression in the site of human placenta implantation. Placenta, 17, 562-572 (1996).
37. OKRAGLY, A., BALWIT, J.M. and HAAK-FRENDSCHO, M., Transforming growth factor β1 (TGFβ1): A biological paradox. Promega Notes, 47, 10-14 (1994).
38. PARK, K., KIM, S.J., BANG, Y.J., PARK, J.G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the trunsformating growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. nat. Acad. Sci. (Wash.), 91, 8772-8776 (1994).
39. PARSONS, R., MYEROFF, L.L., LU, B., WILLSON, J.K.V., MARKOWITZ, S.D., KINZLER, K.W. and VOGELSTEIN, B., Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550 (1995).
40. PERRY, M.E. and LEVINE, A.J., Tumor-suppressor p53 and the cell cycle. Curr. Opin. Genet. Develop., 3, 50-54 (1993).
41. PIPAS, J.M., Common and unique features of T antigens encoded by the polyomavirus group. [Review], J. Virol., 66, 3979-3985 (1992).
42. PONTON, A., COULOMBE, B. and SKUP, D., Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res., 51, 2138-2143 (1991).
43. REDDEL, R.R., KE, Y., GERWIN, B.I., MCMENAMIN, M.G., LECHNER, J.G., SU, R.T., BRASH, D.E., PARK, J-B., RHIM, J.S. and HARRIS, C.C., Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res., 48, 1904-1909 (1988).
44. nd ed.), Cold Harbor Spring Laboratory Press, Cold Harbor Spring, NY (1987).
45. TUCK, A.B., WILSON, S.M., KHOKHA, R. and CHAMBERS, A.F., Different patterns of gene expression in ras-resistant and ras-sensitive cells. J. nat. Cancer. Inst., 83, 485-491 (1991).
46. XUAN, J.W., NILSOM, S.M., CHIN, J.L and CHAMBERS, A.F., Metastatic NIH 3T3 × LTA cll hybrids express 72 kDa type IV collagenase. Anticancer Res., 15, 1227-1233 (1995).
47. YAGEL, S., CASPER, R.F., POWELL, W., PARHAR, R.S. and LALA, P.K., Characterization of pure human first-trimester cytotrophpblast cells in long-term culture: growth pattern, markers and hormone production. Amer. J. Obstet, Gynecol., 160, 938-945 (1989).
48. YAGEL, S., PARHAR, R.S., JEFFREY, J.J. and LALA, P.K., Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J. cell. Physiol., 136, 455-462 (1988).
49. YE, R.D., WUN, T.C. and SADLER, J.E., Mammalian protein secretion without signal peptide removal. J. biol. Chem., 262, 3718-3722 (1981).
50. ZENTELLA, A., WEIS, F.M.B., RALPH, D.A., LAIHO, M. and MASSAGUE, J., Early gene responses to transforming growth factor-β in cells lacking growth suppressive RB function. Mol. cell. Biol., 11, 4952-4958 (1991).